Cochlear Ltd
ASX:COH

Watchlist Manager
Cochlear Ltd Logo
Cochlear Ltd
ASX:COH
Watchlist
Price: 269.37 AUD -2.22% Market Closed
Market Cap: 17.6B AUD
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

The Relative Value of one COH stock under the Base Case scenario is 268.72 AUD. Compared to the current market price of 269.37 AUD, Cochlear Ltd is Fairly Valued.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

COH Relative Value
Base Case
268.72 AUD
Fairly Valued
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

7.7
P/S
P/S
Price to Sales
7.7
vs History
85
vs Industry
17
Median 3Y
8.7
Median 5Y
9.1
Industry
2.2
Forward
7.3
More Details
47.9
P/E
P/E
Price to Earnings
47.9
vs History
50
vs Industry
10
Median 3Y
55.4
Median 5Y
49
Industry
21.9
Forward
42.7
More Details
51.9
P/OCF
P/OCF
Price to OCF
51.9
vs History
14
vs Industry
5
Median 3Y
48
Median 5Y
46.2
Industry
13.5
More Details
78.2
P/FCFE
P/FCFE
Price to FCFE
78.2
vs History
25
vs Industry
6
Median 3Y
74.9
Median 5Y
68.3
Industry
19.3
More Details
9.5
P/B
P/B
Price to Book Value
9.5
vs History
33
vs Industry
7
Median 3Y
9.5
Median 5Y
9.1
Industry
2.1
More Details
7.6
EV/S
EV/S
Enterprise Value to Sales
7.6
vs History
80
vs Industry
16
Median 3Y
8.5
Median 5Y
8.9
Industry
2.3
Forward
7.2
More Details
10
EV/GP
EV/GP
Enterprise Value to Gross Profit
10
vs History
80
vs Industry
21
Median 3Y
11.3
Median 5Y
11.9
Industry
4.8
More Details
32.7
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
32.7
vs History
82
vs Industry
9
Median 3Y
37
Median 5Y
38.7
Industry
11.5
Forward
27.5
More Details
32.7
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
32.7
vs History
82
vs Industry
13
Median 3Y
37
Median 5Y
38.7
Industry
15.6
Forward
31.7
More Details
51.4
EV/OCF
EV/OCF
Enterprise Value to OCF
51.4
vs History
12
vs Industry
6
Median 3Y
47
Median 5Y
45.1
Industry
13.3
More Details
70
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
70
vs History
15
vs Industry
6
Median 3Y
61.4
Median 5Y
61.1
Industry
17.3
More Details
8.3
EV/IC
EV/IC
Enterprise Value to IC
8.3
vs History
57
vs Industry
10
Median 3Y
9
Median 5Y
8.6
Industry
1.8
More Details

Multiples Across Competitors

COH Competitors Multiples
Cochlear Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
AU
Cochlear Ltd
ASX:COH
17.7B AUD 7.7 47.9 32.7 32.7
US
Abbott Laboratories
NYSE:ABT
230B USD 5.4 17 22.1 31.7
US
Intuitive Surgical Inc
NASDAQ:ISRG
188.6B USD 21.6 76.2 60.8 73.1
US
Boston Scientific Corp
NYSE:BSX
154.7B USD 8.8 76.1 35.9 49.7
US
Stryker Corp
NYSE:SYK
144.3B USD 6.4 48.2 24.9 30.1
IE
Medtronic PLC
NYSE:MDT
108.9B USD 3.3 25.6 13.7 19.3
DE
Siemens Healthineers AG
XETRA:SHL
53.7B EUR 2.4 27 15.6 22.2
US
Becton Dickinson and Co
NYSE:BDX
48.9B USD 2.4 28 12.5 22.5
US
Edwards Lifesciences Corp
NYSE:EW
44.5B USD 8 10.7 24.4 26.8
US
IDEXX Laboratories Inc
NASDAQ:IDXX
38.5B USD 9.9 43.4 30.8 34.4
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
266.3B CNY 7.5 23.9 20.9 20.9

See Also

Summary
COH intrinsic value, competitors valuation, and company profile.
DCF Valuation
COH stock valuation using Discount Cash Flow valuation method.
Relative Valuation
COH stock valuation using valuation multiples.
Wall Street Estimates
COH price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
COH stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 252,400+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.